ロード中...
New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
PURPOSE OF REVIEW: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors have emerged as a promising drug class for the treatment of diabetic kidney disease. Developed originally as glucose-lowering drugs by enhancing urinary glucose excretion, these drugs also lower many other renal and cardiovascula...
保存先:
| 出版年: | Curr Diab Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5871636/ https://ncbi.nlm.nih.gov/pubmed/29589183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-018-0992-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|